| Record ID | marc_records_scriblio_net/part25.dat:107734086:850 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part25.dat:107734086:850?format=raw |
LEADER: 00850nam 2200241 a 4500
001 95192664
003 DLC
005 19950907101158.6
008 950816s1993 ctua 000 0 eng
010 $a 95192664
040 $aDLC$cDLC
043 $an-us---
050 00 $aHD9666.5$b.R67 1993
100 1 $aRotheim, Philip.
245 10 $aInert ingredients for drugs /$cPhilip Rotheim, sr. project analyst.
260 $aNorwalk, CT (25 Van Zant St., Norwalk 06855) :$bBusiness Communications Co.,$cc1993.
300 $axvi, 159 leaves :$bill. ;$c29 cm.
440 0 $aBusiness opportunity report ;$vC-068R
500 $a"November 1993"--T.p. verso.
650 0 $aPharmaceutical industry$zUnited States.
650 0 $aControlled release preparations industry$zUnited States.
650 0 $aMarket surveys$zUnited States.
710 2 $aBusiness Communications Co.